[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371112-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371112-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","effect-of-alpha1-antitrypsin-on-pd-1pd-l1-and-egfr-in-colitis-associated-colorectal-cancer-balbc-mouse-model","Effect of Alpha1 Antitrypsin on PD-1/PD-L1 and EGFR in Colitis-Associated Colorectal Cancer BALB/c Mouse Model","","This research investigates whether human alpha-1 antitrypsin (AAT) modulates programmed cell death protein 1 (PD-1), its ligand PD-L1, and epidermal growth factor receptor (EGFR) in colitis-associated colorectal cancer using a chemically induced AOM/DSS BALB/c mouse model. PD-1/PD-L1 and EGFR expression in colon tumor tissues is assessed by qPCR and immunohistochemistry. AAT treatment significantly decreases PD-L1 and EGFR protein levels and represses PD1 and EGFR gene expression. Immunohistochemistry also detects PD1 protein variation with CD4/CD8 positive lymphocytes in the tumor microenvironment. Findings indicate AAT has immunomodulatory potential as a therapeutic strategy for colon cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/effect-of-alpha1-antitrypsin-on-pd-1pd-l1-and-egfr-in-colitis-associated-colorectal-cancer-balbc-mouse-model/371112/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/effect-of-alpha1-antitrypsin-on-pd-1pd-l1-and-egfr-in-colitis-associated-colorectal-cancer-balbc-mouse-model/371112.png","ImageObject",300,407,{"name":42,"@type":43},"acoobca","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary objective of the study?","Question",{"text":63,"@type":64},"To determine whether human alpha-1 antitrypsin affects PD-1, PD-L1, and EGFR expression in colitis-associated colorectal cancer using an AOM/DSS-induced mouse model.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PD-1/PD-L1 and EGFR expressions measured?",{"text":68,"@type":64},"PD-1/PD-L1 and EGFR expression in colon cancer tissues was analyzed using realtime gene expression (qPCR) and immunohistochemistry (IHC).",{"name":70,"@type":61,"acceptedAnswer":71},"What effects did AAT treatment have on PD-L1 and EGFR in tumor tissues?",{"text":72,"@type":64},"AAT treatment reduced PD-L1 protein expression by 63.5% and EGFR protein expression by 48.9% in AOM/DSS-treated mice, with reported statistical significance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371112,1790228258,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:11/01/2024 Acceptance:09/01/2025 Published:09/12/2025 |\n| --- | --- |\n\nEffect of Alpha1 Antitrypsin on PD-1/PD-L1 and EGFR in Colitis-Associated Colorectal Cancer BALB/c Mouse Model  \nMariamM. Al-Omari1, Ayman Okour2, Khaled M. Al-Qaoud2*, Tareq Al-Omari2, Roaa H Marashdeh2, Nesreen M. Bataineh1  \nAbstract  \nObjective: This study aimed to investigate whether Human alpha-1 antitrypsin affects Programmed cell death protein 1 (PD-1) and its ligand (PD-L1) as well as epidermal growth factor receptor (EGFR) expression using a colon cancer tissues in chemically induced colorectal cancer (CRC) model. Previous study indicated a protective role of AAT administration on the development of cancer in CRC mouse model. Methodology: The expression of PD1/PDL1 and EGFR were analyzed in colon cancer tissue collected from (AOM/DSS) CRC mice using both realtime gene expression (qPCR) and immunohistochemistry(IHC) . Results: Study results showed that AAT treatment reduced PD-L1 protein expression by 63.5%(mean H score: 7.8±1.3 to 2.85±0.85, p=0.0004) and EGFR protein expression by 48.9%(mean H score: 1.78±0.76 to 0.91±0.60, p=0.04) in the tissue of AOM/DSS-treated mice. In addition, AAT treatment controlled PD1 gene expression andrepressed EGFR gene expression by 1.4-fold compared toDSS samples. Immunohistochemical analysis revealed various degrees of PD1 protein expression, and CD4 and CD8 positive lymphocytes were found in the tumor microenvironment. Conclusion: These findings suggest that AAT treatment has immunomodulatory properties and may represent a promising therapeutic strategy for colon cancer.  \nKeywords: Cancer Immunotherapy-Immune checkpoints-AOM/DSS-Immunohistochemistry-RT-PCR  \nAsian Pac J Cancer Prev, 26 (9), 3229-3237  \nIntroduction  \nProgrammed death-1 (PD-1) is a co-receptor that is expressed predominantly by T cells, B cells, dendritic cells (DCs), natural killer T (NKT) cells, monocytes and activated macrophages [1] . In physiological circumstances, it works as molecule that limits immune response and therefore prevents excessive tissue damage and protects from autoimmunity by binding to its ligand PD-L1 [2, 3] .  \nPD-L1 is often expressed by various tumor cells and antigen presenting cells in various malignancies [4, 5] . The expression of PD-L1 on normal cells is rare, thus making it a unique immunoinhibitory molecule [1] and a good target for cancer immunotherapy.  \nOneof the established hallmarksof cancer is the evasion of anti-tumor responses in the tumor microenvironment. Moreover, CD8 T cells that have been exhausted express inhibitory immune checkpoints (IC), such as PD-1 and CTLA-4 . T cells undergo apoptosis when they become exhausted and lose their effector functions [6] . However, current anti-tumor immunity-based therapies target the programmed cell death protein-1 (PD-1)/PD-L1 signaling pathway.  \nVarious studies have linked high expression of PD-L1 with a bad prognosis, including ovarian cancer and melanoma. On the contrary, PD-1 and PD-L1 blockade therapy has been shown to reduce tumor growth in ovarian cancer [7] . Yassin and coworkers [8] investigated the expression of PD-1 and its ligands, PDL1, in colitis-associated colorectal cancer (CRC) using an Azoxymethane (AOM)/Dextran Sodium Sulfate (DSS) mouse model. They found a significant increase in PD-1 expression on mucosal T-cell subsets of the colon and the ileum, which correlated with disease progression and T-cell exhaustion. In human studies, after anti-PD-1 antibody administration atthe onset of tumor development to potentially inhibit or prevent tumor progression, there was a reduction in the variation in tumor numbers in individuals with cancer, but it did not affect the tumor burden.  \nHuman alpha-1 antitrypsin (AAT), also known as alpha1 proteinase inhibitor and SERPINA1 (Serine Protease Inhibitor, group A, member 1), is one of the classical acute phase response glycoproteins that circulatesin t","cbCaii5mnxlmSTR1","https://ap.wps.com/l/cbCaii5mnxlmSTR1","pdf",2017241,"English","# Abstract\n## Objective\n## Methodology\n## Results\n## Conclusion\n# Introduction\n## PD-1/PD-L1 in immune regulation\n## Tumor microenvironment immune escape\n## Alpha-1 antitrypsin and cancer context\n## EGFR and colorectal cancer\n## Rationale for the study\n# Materials and Methods","[{\"question\":\"What is the primary objective of the study?\",\"answer\":\"To determine whether human alpha-1 antitrypsin affects PD-1, PD-L1, and EGFR expression in colitis-associated colorectal cancer using an AOM/DSS-induced mouse model.\"},{\"question\":\"How were PD-1/PD-L1 and EGFR expressions measured?\",\"answer\":\"PD-1/PD-L1 and EGFR expression in colon cancer tissues was analyzed using realtime gene expression (qPCR) and immunohistochemistry (IHC).\"},{\"question\":\"What effects did AAT treatment have on PD-L1 and EGFR in tumor tissues?\",\"answer\":\"AAT treatment reduced PD-L1 protein expression by 63.5% and EGFR protein expression by 48.9% in AOM/DSS-treated mice, with reported statistical significance.\"}]","Effect of Alpha1 Antitrypsin on PD-1/PD-L1 and EGFR in Colitis-Associated Colorectal Cancer BALB/c Mouse Model | PDF",1790191276,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f744ee901b622cda103f6d334e202c1b.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1b1b8ef60a8ac0d6263452dc4f5e9b7.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6608448dec03a80ab3451314f6adcb28.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25b67f9f7fab7aa92c124f0c30733149.webp",980,1385]